Selumetinib (AZD6244) is a MEK1/2 inhibitor that inhibits MEK1 (IC50=14 nM) with potent selectivity and is non-ATP-competitive. Selumetinib has antitumor activity and is used for the treatment of neurofibromatosis type 1 (NF1).
Molecular Weight:
457.68
Purity:
99.90%
CAS Number:
[606143-52-6]
Formula:
C17H15BrClFN4O3
Target:
ERK|||MEK|||Apoptosis
T6218
* VAT and and shipping costs not included. Errors and price changes excepted
